MedTrace Logo

Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients With COPD

NCT00469313 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2008-05-22

No results posted yet for this study

Summary

Hypothesis:benefits of inspiratory muscle strenght training with Respifit S decreases symptoms, disability or handicap of patients affected by COPD. The inspiratory fraction (inspiratory capacity IC/ total lung capacity TLC)may be functionally more representative than other traditional indices.

Conditions

Sponsors & Collaborators

  • Hospital Hietzing

    lead OTHER

Principal Investigators

  • Michael Reiter · Hospital Hietzing, A 1130, Vienna, Austria

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469313 on ClinicalTrials.gov